Derm.AI
Overview
Derm.AI is an innovative AI-powered mobile application and software solution developed by Fraunhofer-Gesellschaft, aimed at significantly accelerating the diagnosis of skin cancer. This tool is designed to assist healthcare professionals, particularly dermatologists, in the early detection and assessment of suspicious skin lesions.
The core functionality of Derm.AI lies in its artificial intelligence capabilities, which analyze images of skin lesions to provide rapid insights. Early and accurate diagnosis of skin cancer, especially melanoma, is crucial for improving patient outcomes. By leveraging AI, Derm.AI seeks to enhance diagnostic efficiency and potentially reduce the time from initial observation to definitive diagnosis.
While the provided information highlights its utility in speeding up diagnoses, specific details regarding its integration with existing clinical workflows, regulatory clearances (e.g., FDA), and detailed performance metrics are not explicitly stated in the initial content. Physicians considering Derm.AI would benefit from further information on its validation, accuracy rates, and how it fits into a comprehensive dermatological examination process.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered skin lesion analysis
- Mobile application for ease of use
- Aids in speeding up skin cancer diagnoses
- Potential for early detection of melanoma
Use Cases
- Assisting dermatologists in skin cancer screening
- Enhancing diagnostic efficiency for suspicious lesions
- Supporting early intervention for skin cancer
Details
| Category | Dermatology AI |
| Pricing |
Freemium / subscription / per-unit
|
| Free Trial | Unknown |
| Deployment | Mobile App, Cloud-based (API) |
| Mobile App | 1 |
| API Available | Unknown |
| Data Export | Unknown |
| Languages | English, and others including Bangla, Gujarati, Kannada, Malayalam, Marathi, Odia, Punjabi, Slovenian, Tamil, Telugu, and Urdu for some versions of Derm AI. |
| Training | Unknown |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Unknown AI-estimated DERM (Skin Analytics) has achieved regulatory approval for its autonomous AI skin cancer detection system in Europe, making it the world's first legally authorized AI to independently make clinical decisions on skin cancer without oversight. It is also the first UKCA marked Class IIa AIaMD for skin cancer. |
| GDPR | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Dermatology Ai |
Social Proof
| Customers | DermGPT is trusted by 6,000+ dermatologists. DERM (Skin Analytics) has assessed over 110,000 cases in the UK. First Derm is trusted by over 250,000 users worldwide. |
| Notable | Shared Services of the Ministry of Health (Portugal)IPO CoimbraCHUPULS GuardaBolton NHS Foundation Trust (UK)Arts en Zorg (The Netherlands) |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
Derm.AI, or similar AI-powered dermatology tools, are emerging as promising aids in skin health, primarily for screening, monitoring, and administrative tasks, rather than as replacements for human dermatologists. While these tools offer convenience and can help prioritize high-risk cases, concerns exist regarding diagnostic accuracy, particularly for diverse skin tones, and the potential for misinformation or over-cautious flagging of benign lesions. Physicians generally see AI as an augmentation to their practice, reducing administrative burdens and improving triage efficiency, but emphasize the irreplaceable role of human empathy, surgical skill, and complex decision-making.
Overall: MixedStrengths
- Can analyze skin and recommend products based on unique skin profiles, allergies, and preferences.
- Offers instant AI-powered skin analysis, detecting common concerns like acne, aging, and redness with severity scores.
- Provides personalized product recommendations backed by ingredient science, with routine updates.
- Helps track skin transformation with visual timelines and severity trends.
- Can reduce administrative burden for physicians, allowing them to focus more on patient care.
- Potential for triage efficiency by prioritizing high-risk cases and identifying subtle patterns in inflammatory skin diseases.
Limitations
- AI in dermatology often has a bias toward lighter skin types, leading to potential inaccuracies for patients with skin of color.
- Some users report issues with unexpected subscription fees and unauthorized payments.
- AI models may over-call skin cancer, leading to unnecessary biopsies of benign lesions.
- AI tools may struggle with conditions that look similar in 2D photos but behave differently in real life.
- AI cannot perform physical exams, take a full medical history, or conduct biopsies, which are crucial for definitive diagnoses.
- Concerns exist about misinformation and incorrect diagnoses, as AI can reinforce incorrect information if the initial input is flawed.
Based on reviews from: Reddit, Apple App Store, PubMed, JDDonline, Dermatology Times, AMN Healthcare, ScanSkinAI, HCPLive, Nolla Health, Capterra, Trustpilot, G2, NHS Health Research Authority, MedNexus, Autoderm, YouTube, JCAD, EHRranker.com
Last updated: 2026-09-13
Ratings & Reviews
No reviews yet. Be the first to review this tool!
